UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Blood cancer care in a resource limited setting during the Covid-19 outbreak; a single center experience from Sri Lanka

PloS one, 2021-09, Vol.16 (9), p.e0256941-e0256941

2021

Volltextzugriff (PDF)

Brodie's abscess in a patient presenting with postchemotherapy neutropenic sepsis

EJHaem, 2021-08, Vol.2 (3), p.638-639

2021

Volltextzugriff (PDF)

Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting

JCO global oncology, 2024-03, Vol.10 (10), p.e2300412-e2300412

2024

Volltextzugriff (PDF)

Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2009-02, Vol.27 (5), p.763-769

2009

Volltextzugriff (PDF)

Applicability of protocols from high-income countries in a resource limited setting; real world data of histopathology, clinical features and long-term outcome of Hodgkin Lymphoma in Sri Lanka

EClinicalMedicine, 2021-08, Vol.38, p.100998-100998, Article 100998

2021

Volltextzugriff (PDF)

Response and Survival Estimates of Patients With Plasma Cell Myeloma in a Resource-Constrained Setting Using Protocols From High-Income Countries: A Single-Center Experience From Sri Lanka

JCO global oncology, 2022-06, Vol.8 (8), p.e2100352

2022

Volltextzugriff (PDF)

The Novel Nuclear Factor-κB Inhibitor LC-1 Is Equipotent in Poor Prognostic Subsets of Chronic Lymphocytic Leukemia and Shows Strong Synergy with Fludarabine

Clinical cancer research, 2008-12, Vol.14 (24), p.8102-8111

2008

Volltextzugriff (PDF)

Targeting transcription factors for therapeutic benefit

Molecular bioSystems, 2008, Vol.4 (9), p.909-919

2008

Volltextzugriff (PDF)

Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy

European journal of haematology, 2009-09, Vol.83 (3), p.277-277

2009

Volltextzugriff (PDF)

Acute renal failure as the presenting feature of leukaemic infiltration in chronic lymphocytic leukaemia

Clinical and experimental nephrology, 2009-04, Vol.13 (2), p.179-181

2009

Volltextzugriff (PDF)

Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38

Haematologica (Roma), 2010-03, Vol.95 (3), p.514-517

2010

Volltextzugriff (PDF)

IgM multiple myeloma: a diagnostic challenge in a patient with coexisting chronic lymphocytic leukaemia

International journal of hematology, 2008-11, Vol.88 (4), p.424-427

2008

Volltextzugriff (PDF)

Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers

Blood, 2008-11, Vol.112 (9), p.3807-3817

2008

Volltextzugriff (PDF)

Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis

Blood, 2010-09, Vol.116 (11), p.1899-1907

2010

Volltextzugriff (PDF)

Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route

Blood, 2011-11, Vol.118 (22), p.5799-5802

2011

Volltextzugriff (PDF)

The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target

Blood, 2008-05, Vol.111 (9), p.4681-4689

2008

Volltextzugriff (PDF)

Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-κB Activation and De novo Gene Transcription

Cancer research (Chicago, Ill.), 2010-10, Vol.70 (19), p.7523-7533

2010

Volltextzugriff (PDF)

Aminopeptidase inhibition by the novel agent CHR-2797 (tosedostat) for the therapy of acute myeloid leukemia

Leukemia research, 2011-05, Vol.35 (5), p.677-681

2011

Volltextzugriff (PDF)

Treatment options for high-risk chronic lymphocytic leukaemia

Therapeutic Advances in Hematology, 2011-06, Vol.2 (3), p.147-159

2011

Volltextzugriff (PDF)

NF- κB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia

Future oncology (London, England), 2009-09, Vol.5 (7), p.1027-1037

2009

Volltextzugriff (PDF)

Defining the prognosis of early stage chronic lymphocytic leukaemia patients

British journal of haematology, 2012-02, Vol.156 (4), p.499-507

2012

Volltextzugriff (PDF)

Nuclear factor‐κB as a potential therapeutic target for the novel cytotoxic agent LC‐1 in acute myeloid leukaemia

British journal of haematology, 2008-12, Vol.143 (5), p.661-671

2008

Volltextzugriff (PDF)

CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL

Leukemia research, 2011-06, Vol.35 (6), p.750-756

2011

Volltextzugriff (PDF)

The blood film as a diagnostic tool

British journal of hospital medicine (London, England : 2005), 2008-09, Vol.69 (9), p.M144-M147

2008

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Humans
(25)
Hematology
(17)
Biological And Medical Sciences
(12)
Middle Aged
(12)
Hematologic And Hematopoietic Diseases
(11)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(11)
Male
(11)
Medical Sciences
(11)
Adult
(9)
Oncology
(9)
Aged
(8)
Leukemia, Lymphocytic, Chronic, B-Cell - Pathology
(8)
Prognosis
(8)
Female
(7)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(7)
Aged, 80 And Over
(6)
Antineoplastic Agents - Pharmacology
(5)
Cll
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(13)
British Journal Of Haematology
(5)
British Journal Of Hospital Medicine
(3)
Cancer Research
(3)
Future Oncology
(3)
Clinical Cancer Research
(2)
Ejhaem
(2)
Jco Global Oncology
(2)
Leukemia Research
(2)
Molecular Cancer Therapeutics
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Blood cancer care in a resource limited setting during the Covid-19 outbreak; a single center experience from Sri Lanka

Brodie's abscess in a patient presenting with postchemotherapy neutropenic sepsis

Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting

Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia

Applicability of protocols from high-income countries in a resource limited setting; real world data of histopathology, clinical features and long-term outcome of Hodgkin Lymphoma in Sri Lanka

Applicability of Western protocols in resource‐limited setting: Real‐world data of long‐term outcome of intensive treatment of adult acute myeloid leukaemia in Sri Lanka

Response and Survival Estimates of Patients With Plasma Cell Myeloma in a Resource-Constrained Setting Using Protocols From High-Income Countries: A Single-Center Experience From Sri Lanka

The Novel Nuclear Factor-κB Inhibitor LC-1 Is Equipotent in Poor Prognostic Subsets of Chronic Lymphocytic Leukemia and Shows Strong Synergy with Fludarabine

Targeting transcription factors for therapeutic benefit

Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy

Acute renal failure as the presenting feature of leukaemic infiltration in chronic lymphocytic leukaemia

Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38

IgM multiple myeloma: a diagnostic challenge in a patient with coexisting chronic lymphocytic leukaemia

Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers

Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis

Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route

The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target

Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-κB Activation and De novo Gene Transcription

Aminopeptidase inhibition by the novel agent CHR-2797 (tosedostat) for the therapy of acute myeloid leukemia

Treatment options for high-risk chronic lymphocytic leukaemia

NF- κB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia

Defining the prognosis of early stage chronic lymphocytic leukaemia patients

Nuclear factor‐κB as a potential therapeutic target for the novel cytotoxic agent LC‐1 in acute myeloid leukaemia

CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL

The blood film as a diagnostic tool

Suchergebnisse filtern